Compounds with species and cell type specific toxicity identified in a 2000 compound drug screen of neural stem cells and rat mixed cortical neurons.

Human primary neural tissue is a vital component for the quick and simple determination of chemical compound neurotoxicity in vitro. In particular, such tissue would be ideal for high-throughput screens that can be used to identify novel neurotoxic or neurotherapeutic compounds. We have previously established a high-throughput screening platform using human induced pluripotent stem cell (iPSC)-derived neural stem cells (NSCs) and neurons. In this study, we conducted a 2000 compound screen with human NSCs and rat cortical cells to identify compounds that are selectively toxic to each group. Approximately 100 of the tested compounds showed specific toxicity to human NSCs. A secondary screen of a small subset of compounds from the primary screen on human iPSCs, NSC-derived neurons, and fetal astrocytes validated the results from >80% of these compounds with some showing cell specific toxicity. Amongst those compounds were several cardiac glycosides, all of which were selectively toxic to the human cells. As the screen was able to reliably identify neurotoxicants, many with species and cell-type specificity, this study demonstrates the feasibility of this NSC-driven platform for higher-throughput neurotoxicity screens.

[1]  Abigail J. Rao,et al.  Expression of Nestin by Neural Cells in the Adult Rat and Human Brain , 2011, PloS one.

[2]  V. Velculescu,et al.  Sodium ion channel mutations in glioblastoma patients correlate with shorter survival , 2011, Molecular Cancer.

[3]  A. Ludolph,et al.  3-Nitropropionic Acid - Exogenous Animal Neurotoxin and Possible Human Striatal Toxin , 1991, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[4]  S. Jahan,et al.  Differentiating neurons derived from human umbilical cord blood stem cells work as a test system for developmental neurotoxicity , 2015, Molecular Neurobiology.

[5]  Tzong-Shiue Yu,et al.  A restricted cell population propagates glioblastoma growth after chemotherapy , 2012 .

[6]  S. Nath,et al.  Catechins protect neurons against mitochondrial toxins and HIV proteins via activation of the BDNF pathway , 2012, Journal of NeuroVirology.

[7]  D. D. de Groot,et al.  Neural progenitor cells as models for high-throughput screens of developmental neurotoxicity: state of the science. , 2010, Neurotoxicology and teratology.

[8]  Tzong-Shiue Yu,et al.  A restricted cell population propagates glioblastoma growth following chemotherapy , 2012, Nature.

[9]  L. Meijer,et al.  Inhibition of Tat-mediated HIV-1 replication and neurotoxicity by novel GSK3-beta inhibitors. , 2011, Virology.

[10]  Chengyu Liu,et al.  Stable Enhanced Green Fluorescent Protein Expression After Differentiation and Transplantation of Reporter Human Induced Pluripotent Stem Cells Generated by AAVS1 Transcription Activator‐Like Effector Nucleases , 2014, Stem cells translational medicine.

[11]  L. Studer,et al.  Identification of Compounds that Rescue IKBKAP Expression in Familial Dysautonomia-iPS Cells , 2012, Nature Biotechnology.

[12]  Satoshi Tanaka,et al.  Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML , 2010, Nature Biotechnology.

[13]  Anastasia G. Efthymiou,et al.  Functional Screening Assays with Neurons Generated from Pluripotent Stem Cell–Derived Neural Stem Cells , 2014, Journal of biomolecular screening.

[14]  M. Zhan,et al.  Identification by Automated Screening of a Small Molecule that Selectively Eliminates Neural Stem Cells Derived from hESCs but Not Dopamine Neurons , 2009, PloS one.

[15]  A. Le,et al.  Targeting Cancer Stem Cells in Oral Cancer. , 2016, Journal of the California Dental Association.

[16]  T. Wurdinger,et al.  Lanatoside C sensitizes glioblastoma cells to tumor necrosis factor-related apoptosis-inducing ligand and induces an alternative cell death pathway. , 2011, Neuro-oncology.

[17]  Anastasia G. Efthymiou,et al.  Comparison of the Gene Expression Profiles of Human Fetal Cortical Astrocytes with Pluripotent Stem Cell Derived Neural Stem Cells Identifies Human Astrocyte Markers and Signaling Pathways and Transcription Factors Active in Human Astrocytes , 2014, PloS one.

[18]  N. Haughey,et al.  The Human Immunodeficiency Virus Coat Protein gp120 Promotes Forward Trafficking and Surface Clustering of NMDA Receptors in Membrane Microdomains , 2011, The Journal of Neuroscience.

[19]  Su-Chun Zhang,et al.  Human oligodendrocytes from embryonic stem cells: conserved SHH signaling networks and divergent FGF effects , 2009, Development.

[20]  V. Herrera,et al.  Three differentially expressed Na,K-ATPase alpha subunit isoforms: structural and functional implications , 1987, The Journal of cell biology.

[21]  M. Rao,et al.  Efficient Generation of Astrocytes from Human Pluripotent Stem Cells in Defined Conditions , 2013, Stem cells.

[22]  Jessica Mariani,et al.  Impaired generation of mature neurons by neural stem cells from hypomorphic Sox2 mutants , 2008, Development.

[23]  M. Rao,et al.  Xeno-Free Defined Conditions for Culture of Human Embryonic Stem Cells, Neural Stem Cells and Dopaminergic Neurons Derived from Them , 2009, PloS one.

[24]  Digitoxin sensitizes glioma cells to TRAIL-mediated apoptosis by upregulation of death receptor 5 and downregulation of survivin , 2014, Anti-cancer drugs.

[25]  H. Gelderblom,et al.  Cardiac glycosides in cancer therapy: from preclinical investigations towards clinical trials , 2013, Investigational New Drugs.

[26]  L. Rubin,et al.  A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS. , 2013, Cell stem cell.

[27]  M. Mattson,et al.  Perturbation of sphingolipid metabolism and ceramide production in HIV‐dementia , 2004, Annals of neurology.

[28]  Shinn-Zong Lin,et al.  Targeting Cancer Stem Cells for Treatment of Glioblastoma Multiforme , 2013, Cell transplantation.

[29]  Jennifer M. Bolin,et al.  Chemically defined conditions for human iPS cell derivation and culture , 2011, Nature Methods.

[30]  A. Nath,et al.  The immunophilin ligand GPI1046 protects neurons from the lethal effects of the HIV‐1 proteins gp120 and Tat by modulating endoplasmic reticulum calcium load , 2006, Journal of neurochemistry.

[31]  D. Rice,et al.  Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. , 2000, Environmental health perspectives.

[32]  Abby A. Li,et al.  Strategies and tools for preventing neurotoxicity: to test, to predict and how to do it. , 2012, Neurotoxicology.

[33]  J. Bailar,et al.  Toxicity Testing in the 21st Century: A Vision and a Strategy , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.

[34]  A. Nath,et al.  Neuroprotective and Antiretroviral Effects of the Immunophilin ligand GPI 1046 , 2007, Journal of Neuroimmune Pharmacology.

[35]  N. Socci,et al.  High-throughput screening assay for the identification of compounds regulating self-renewal and differentiation in human embryonic stem cells. , 2008, Cell stem cell.

[36]  O. Yanuka,et al.  Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen. , 2013, Cell stem cell.

[37]  M. Tomishima,et al.  Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling , 2009, Nature Biotechnology.

[38]  J. Sheng,et al.  Efficient and Rapid Derivation of Primitive Neural Stem Cells and Generation of Brain Subtype Neurons From Human Pluripotent Stem Cells , 2013, Stem cells translational medicine.

[39]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[40]  J. Lingrel,et al.  Comparison of the substrate dependence properties of the rat Na,K-ATPase alpha 1, alpha 2, and alpha 3 isoforms expressed in HeLa cells. , 1991, The Journal of biological chemistry.